Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. Issue 5 (16th April 2019)

Record Type:
Journal Article
Title:
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. Issue 5 (16th April 2019)
Main Title:
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis
Authors:
Mascarenhas, John
Baer, Maria R.
Kessler, Craig
Hexner, Elizabeth
Tremblay, Douglas
Price, Leah
Sandy, Lonette
Weinberg, Rona
Pahl, Heike
Silverman, Lewis R.
Goldberg, Judith D.
Kosiorek, Heidi
Dueck, Amylou C.
Hoffman, Ronald
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 60:Issue 5(2019)
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 5(2019)
Issue Display:
Volume 60, Issue 5 (2019)
Year:
2019
Volume:
60
Issue:
5
Issue Sort Value:
2019-0060-0005-0000
Page Start:
1343
Page End:
1345
Publication Date:
2019-04-16
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2018.1532509 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
9997.xml